Literature DB >> 16181542

[Effect of intestinal cytochrome P450 3A on phytochemical presystemic metabolism].

Fang Xia1, Xiao-yin Chen.   

Abstract

Phytochemicals, orally administered substances, are found to undergo presystemic metabolism mainly in the intestine. Although early researches confirmed the role of intestinal bacteria in phytochemical presystemic metabolism, along with the development of molecular biology in investigating intestinal metabolism, a breakthrough has been won in research into metabolizing enzymes and transporters in intestine, which demands more attention and further studies. Recently, Cytochrome P450 3A has been found to be the most effective enzyme in mediating both oxidative (PhaseI) and conjugative (PhaseII) metabolism in the intestine. The present review summarizes the current findings correlated with the effect of intestinal cytochrome P450 3A on phytochemical presystemic metabolism, which provides a good basis for further research on phytochemical pharmacokinetics.

Mesh:

Substances:

Year:  2005        PMID: 16181542     DOI: 10.1007/bf02836512

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  23 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Effects of grapefruit juice ingestion--pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men.

Authors:  J Lundahl; C G Regårdh; B Edgar; G Johnsson
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

Review 3.  Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

Authors:  V J Wacher; C Y Wu; L Z Benet
Journal:  Mol Carcinog       Date:  1995-07       Impact factor: 4.784

4.  Mechanism of gastrointestinal absorption of glycyrrhizin in rats.

Authors:  Z Wang; Y Kurosaki; T Nakayama; T Kimura
Journal:  Biol Pharm Bull       Date:  1994-10       Impact factor: 2.233

5.  In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.

Authors:  Carolyn L Cummins; Laurent Salphati; Michael J Reid; Leslie Z Benet
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

Review 6.  Cytochrome P450 enzymes in the generation of commercial products.

Authors:  F Peter Guengerich
Journal:  Nat Rev Drug Discov       Date:  2002-05       Impact factor: 84.694

Review 7.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

8.  CYP3A gene expression in human gut epithelium.

Authors:  J C Kolars; K S Lown; P Schmiedlin-Ren; M Ghosh; C Fang; S A Wrighton; R M Merion; P B Watkins
Journal:  Pharmacogenetics       Date:  1994-10

9.  First-pass metabolism of midazolam by the human intestine.

Authors:  M F Paine; D D Shen; K L Kunze; J D Perkins; C L Marsh; J P McVicar; D M Barr; B S Gillies; K E Thummel
Journal:  Clin Pharmacol Ther       Date:  1996-07       Impact factor: 6.875

10.  Interaction between grapefruit juice and midazolam in humans.

Authors:  H H Kupferschmidt; H R Ha; W H Ziegler; P J Meier; S Krähenbühl
Journal:  Clin Pharmacol Ther       Date:  1995-07       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.